Who owns MINERALYS THERAPEUTICS INC?
- Ticker: MLYS
- CUSIP Number: 603170101
Tip: Access positions for across all investors
Analyze quarterly positions in Mineralys Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Mineralys Therapeutics stock
Who bought or sold MINERALYS THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Samsara BioCapital | 5.1M | $66M | 12% | Mar 2024 |
|
RA Capital Management | 4.9M | $63M | 53% | Mar 2024 |
|
OrbiMed Advisors | 2.0M | $26M | 100% | Mar 2024 |
|
Sr One Capital Management | 1.8M | $15M | 0% | Dec 2023 |
|
BlackRock | 1.3M | $17M | 50% | Mar 2024 |
|
Laurion Capital Management | 1.3M | $17M | 13% | Mar 2024 |
|
Braidwell | 1.1M | $15M | -43% | Mar 2024 |
|
Vanguard Group | 983k | $13M | 1% | Mar 2024 |
|
Franklin Resources | 908k | $12M | 30% | Mar 2024 |
|
Rock Springs Capital Management | 793k | $10M | -32% | Mar 2024 |
|
American Century Companies | 720k | $9.3M | 72% | Mar 2024 |
|
Sphera Funds Management | 659k | $8.5M | -11% | Mar 2024 |
|
VR Adviser | 556k | $7.2M | 100% | Mar 2024 |
|
Octagon Capital Advisors | 550k | $7.1M | 100% | Mar 2024 |
|
Blue Owl Capital Holdings | 541k | $7.0M | -5% | Mar 2024 |
|
Morgan Stanley | 522k | $6.7M | 288% | Mar 2024 |
|
Geode Capital Management | 383k | $4.9M | 28% | Mar 2024 |
|
Nantahala Capital Management | 333k | $4.3M | 100% | Mar 2024 |
|
Northern Trust | 146k | $1.9M | 31% | Mar 2024 |
|
Ensign Peak Advisors | 125k | $1.6M | 0% | Mar 2024 |
|
ExodusPoint Capital Management | 122k | $1.6M | -23% | Mar 2024 |
|
Charles Schwab Investment Management | 121k | $1.6M | 0% | Mar 2024 |
|
DAFNA Capital Management | 90k | $1.2M | 492% | Mar 2024 |
|
Bank of America Corporation | 83k | $1.1M | 69% | Mar 2024 |
|
NEOS Investment Management | 71k | $913k | 100% | Mar 2024 |
|
Lion Point Capital | 60k | $775k | 100% | Mar 2024 |
|
UBS O'Connor | 59k | $755k | 100% | Mar 2024 |
|
Goldman Sachs Group | 49k | $636k | 8% | Mar 2024 |
|
Bank of New York Mellon | 49k | $634k | 5% | Mar 2024 |
|
Point72 Asset Management | 48k | $617k | -63% | Mar 2024 |
|
Millennium Management | 37k | $482k | -90% | Mar 2024 |
|
Nuveen Asset Management | 35k | $450k | 82% | Mar 2024 |
|
ALPS Advisors | 27k | $229k | -12% | Dec 2023 |
|
ADAR1 Capital Management | 24k | $310k | 100% | Mar 2024 |
|
Rhumbline Advisers | 23k | $291k | 10% | Mar 2024 |
|
Jump Financial | 21k | $176k | -37% | Dec 2023 |
|
Federated Investors | 20k | $172k | -10% | Dec 2023 |
|
UBS Group | 20k | $255k | -9% | Mar 2024 |
|
Jpmorgan Chase & Co | 19k | $242k | -20% | Mar 2024 |
|
Citadel Advisors | 16k | $212k | -86% | Mar 2024 |
|
Alliancebernstein | 16k | $136k | 0% | Dec 2023 |
|
Two Sigma Investments | 16k | $202k | -76% | Mar 2024 |
|
XTX Topco | 15k | $194k | -20% | Mar 2024 |
|
Wells Fargo & Company | 14k | $186k | 80% | Mar 2024 |
|
Jane Street | 14k | $183k | 100% | Mar 2024 |
|
Barclays | 14k | $176k | -49% | Mar 2024 |
|
MetLife Investment Advisors | 11k | $98k | 62% | Dec 2023 |
|
Letko, Brosseau & Associates | 11k | $147k | 0% | Mar 2024 |
|
Change Path | 11k | $92k | 100% | Dec 2023 |
|
Virtus ETF Advisers | 11k | $136k | -6% | Mar 2024 |
|
American International | 9.7k | $83k | 39% | Dec 2023 |
|
Bellevue Group | 9.2k | $119k | 100% | Mar 2024 |
|
New York State Common Retirement Fund | 8.4k | $109k | 140% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 8.3k | $108k | 100% | Mar 2024 |
|
China Universal Asset Management | 7.9k | $102k | 67% | Mar 2024 |
|
CWM | 5.9k | $76k | 0% | Mar 2024 |
|
Citigroup | 4.0k | $51k | 4% | Mar 2024 |
|
Cubist Systematic Strategies | 2.8k | $36k | -84% | Mar 2024 |
|
Pnc Financial Services | 2.2k | $29k | -46% | Mar 2024 |
|
California State Teachers Retirement System | 2.0k | $25k | -37% | Mar 2024 |
|
Summit Investment Advisors | 1.9k | $24k | 93% | Mar 2024 |
|
Legal & General Group | 1.7k | $22k | 0% | Mar 2024 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 1.6k | $20k | -36% | Mar 2024 |
|
FMR | 1.5k | $20k | -100% | Mar 2024 |
|
Metropolitan Life Insurance Company | 1.2k | $11k | 70% | Dec 2023 |
|
Qube Research & Technologies | 1.0k | $13k | 121% | Mar 2024 |
|
Brian McDonald | 690.00 | $8.9k | 35% | Mar 2024 |
|
Amalgamated Bank | 501.00 | $6.0k | -71% | Mar 2024 |
|
Royal Bank of Canada | 444.00 | $0 | -93% | Mar 2024 |
|
Massmutual Trust | 319.00 | $4.1k | 0% | Mar 2024 |
|
Tower Research Capital | 295.00 | $3.8k | -97% | Mar 2024 |
|
Daiwa Securities Group | 152.00 | $2.0k | 100% | Mar 2024 |
|
Quadrant Capital | 129.00 | $1.7k | 0% | Mar 2024 |
|
Efficient Wealth Management | 78.00 | $2.0k | 0% | Mar 2024 |
|
Versant Capital Management | 63.00 | $813.002400 | 0% | Mar 2024 |
|
Private Wealth Management Group | 50.00 | $646.000000 | 0% | Mar 2024 |
|
Northwestern Mutual Wealth Management Company | 36.00 | $465.001200 | 100% | Mar 2024 |
|
Parallel Advisors | 22.00 | $284.000200 | -86% | Mar 2024 |
|
Russell Investments | 17.00 | $219.000800 | -100% | Mar 2024 |
|
Farther Finance Advisors | 17.00 | $221.999600 | 0% | Mar 2024 |
|
NISA Investment Advisors | 4.00 | $52.000000 | 100% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 3.00 | $38.000100 | 100% | Mar 2024 |
|
Who sold out of Mineralys Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Woodline Partners | Sep 2023 | 175k | $1.7M |
Walleye Trading Advisors | Dec 2023 | 56k | $481k |
Alyeska Investment Group | Dec 2023 | 38k | $323k |
CornerCap Investment Counsel | Dec 2023 | 22k | $191k |
Raymond James Financial Services Advisors | Dec 2023 | 15k | $126k |
PDT Partners | Dec 2023 | 14k | $120k |
SG Americas Securities | Dec 2023 | 10k | $87k |
Glassman Wealth Services | Dec 2023 | 372.00 | $3.2k |
Point72 Middle East FZE | Dec 2023 | 135.00 | $1.2k |
Advisor Group Holdings | Dec 2023 | 77.00 | $661.999800 |